Essenlix Corporation
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Clinical Evaluation of the iMOST-X1 Hematology Analyzer - Matrix Study (NCT04778553) | Essenlix Corporation | 2020-10-19 |
Track Essenlix Corporation automatically
Every clearance here is in the API, with alerts when new ones post.